Science Explorer Back to mapMap
Discussion
Researcher · Istituto Oncologico Veneto · Italy

Federica Miglietta

Federica Miglietta publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research and Advanced Breast Cancer Therapies.

ORCID 0000-0001-6203-874X OpenAlex
World rank
#319,804
of 7,710,434 ranked researchers
Rank in Italy
#8,156
of 242,206
Works
201
Citations
3k
Citations per work
14.9
h-index
29
i10-index 55Top 12% in Oncology
Federica Miglietta

What does Federica Miglietta research?

Federica Miglietta's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (25%).

Health Sciences: 113 works · 56.4% of their workMedicine: 113 works · 56.4% of their workOncology: 69 works · 34.3% of their workPulmonary and Respiratory Medicine: 37 works · 18.4% of their workRadiology, Nuclear Medicine and Imaging: 7 works · 3.7% of their workLife Sciences: 50 works · 25.1% of their workBiochemistry, Genetics and Molecular Biology: 50 works · 25.1% of their workCancer Research: 37 works · 18.2% of their workGenetics: 7 works · 3.7% of their workMolecular Biology: 6 works · 3.2% of their workEverything else: 37 works · 18.5% of their workTHEIR WORKFedericaMiglietta201works
Life Sciences25%Health Sciences56%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine11356.4%
    1. Biochemistry, Genetics and Molecular Biology5025.1%
  3. Everything else3718.5%
  1. 1Oncology34% of their works
  2. 2Pulmonary and Respiratory Medicine18% of their works
  3. 3Cancer Research18% of their works
  4. 4Genetics4% of their works
  5. 5Radiology, Nuclear Medicine and Imaging4% of their works
  6. 6Molecular Biology3% of their works

Research topics

Which keywords describe Federica Miglietta's research?

The keywords of their largest research topics: Breast Cancer, Breast Tumours, Gene Expression, Chemotherapy, Metastatic Breast Cancer, HER2, Trastuzumab and CDK4/6 Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Breast Cancer772 topics
  2. Breast Tumours581 topic
  3. Gene Expression581 topic
  4. Chemotherapy552 topics
  5. Metastatic Breast Cancer492 topics
  6. HER2411 topic
  7. Trastuzumab411 topic
  8. CDK4/6 Inhibitors361 topic
  9. Palbociclib361 topic
  10. Immunotherapy352 topics
  11. Immune Checkpoint Blockade321 topic
  12. PD-1 and PD-L1321 topic
  13. Targeted Therapy252 topics
  14. Brain Metastases211 topic
  15. Radiosurgery211 topic
  16. Genomic Profiles141 topic
  17. Small-Cell Lung Cancer141 topic
  18. Chemotherapy-Induced Peripheral Neuropathy131 topic
  19. Taxanes131 topic
  20. Cancer Genomics111 topic
  21. Mutational Signatures111 topic

Where does Federica Miglietta work?

Federica Miglietta's main affiliation in the publication record is Istituto Oncologico Veneto, Italy.

How many publications and citations does Federica Miglietta have?

OpenAlex counts 201 works and 3,003 citations for Federica Miglietta, an h-index of 29, ranking #319,804 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Federica Miglietta

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Federica Miglietta. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.